单细胞分辨率下的胎盘植入谱系疾病:蜕膜与内皮中边界限制的丧失
本研究采用单细胞RNA测序和空间转录组学,对6例胎盘植入谱系疾病(PAS)胎盘和6例对照胎盘进行细胞异质性分析,并在同一PAS胎盘的不同附着部位取材。研究发现内皮-基质细胞群基因表达差异最大,涉及胶原基因(COL3A1)、生长因子(EGFL6、HGF)和血管生成相关基因(DLK1、PECAM1),结论认为PAS的病因学解释应从「侵袭性滋养细胞」转向蜕膜中「边界限制的丧失」。
要点
- PAS胎盘与对照胎盘之间转录谱差异显著,多数差异见于附着部位。
- 内皮-基质细胞群基因表达差异最大,涉及COL3A1、EGFL6、HGF、DLK1和PECAM1。
- 同一PAS胎盘附着与非附着部位间存在宫内趋向性差异,涉及BMP5和SPP1。
核心结论
- PAS的特征是蜕膜中「边界限制的丧失」,而非「侵袭性滋养细胞」。
- 基质和内皮细胞通过细胞外基质、生长因子和血管生成的变化参与PAS发病。
- 研究所鉴定的基因靶点可能用于改进早期妊娠诊断、追踪疾病进展和指导治疗发现。
研究设计与样本
- 研究采用单细胞RNA测序和空间转录组学技术。
- 共纳入12例胎盘,其中6例为PAS胎盘,6例为对照胎盘。
- 每例PAS胎盘在附着部位和非附着部位取多块活检。
- 单细胞和空间转录组分别使用10× Chromium和NanoString GeoMx数字空间分析平台建库。
主要发现
- PAS与对照胎盘之间转录谱差异显著,多数差异见于附着部位。
- 同一PAS胎盘附着部位与非附着部位之间也存在差异。
- 内皮-基质细胞群基因表达差异最大,由胶原基因(COL3A1)、生长因子(EGFL6、HGF)和血管生成相关基因(DLK1、PECAM1)的变化驱动。
- 同一PAS胎盘附着与非附着部位间的宫内趋向性由内皮-基质细胞差异驱动,BMP5和SPP1差异显著。
关键数值与推荐
- 差异基因表达分析使用Seurat和GeoMxTools R包等生物信息学工具。
- 多重检验校正使用Clipper方法。
- 原位杂交使用RNAscope,免疫组化用于评估蛋白表达。
临床怎么用
- 研究所鉴定的基因靶点可能用于改进早期妊娠诊断、追踪疾病进展和指导治疗发现。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Placenta accreta spectrum disorders are associated with severe maternal morbidity and mortality. Placenta accreta spectrum disorders involve excessive adherence of the placenta preventing separation at birth. Traditionally, this condition has been attributed to excessive trophoblast invasion; however, an alternative view is a fundamental defect in decidual biology. OBJECTIVE: This study aimed to gain insights into the understanding of placenta accreta spectrum disorder by using single-cell and spatially resolved transcriptomics to characterize cellular heterogeneity at the maternal-fetal interface in placenta accreta spectrum disorders. STUDY DESIGN: To assess cellular heterogeneity and the function of cell types, single-cell RNA sequencing and spatially resolved transcriptomics were used. A total of 12 placentas were included, 6 placentas with placenta accreta spectrum disorder and 6 controls. For each placenta with placenta accreta spectrum disorder, multiple biopsies were taken at the following sites: placenta accreta spectrum adherent and nonadherent sites in the same placenta. Of note, 2 platforms were used to generate libraries: the 10× Chromium and NanoString GeoMX Digital Spatial Profiler for single-cell and spatially resolved transcriptomes, respectively. Differential gene expression analysis was performed using a suite of bioinformatic tools (Seurat and GeoMxTools R packages). Correction for multiple testing was performed using Clipper. In situ hybridization was performed with RNAscope, and immunohistochemistry was used to assess protein expression. RESULTS: In creating a placenta accreta cell atlas, there were dramatic difference in the transcriptional profile by site of biopsy between placenta accreta spectrum and controls. Most of the differences were noted at the site of adherence; however, differences existed within the placenta between the adherent and nonadherent site of the same placenta in placenta accreta. Among all cell types, the endothelial-stromal populations exhibited the greatest difference in gene expression, driven by changes in collagen genes, namely collagen type III alpha 1 chain (COL3A1), growth factors, epidermal growth factor-like protein 6 (EGFL6), and hepatocyte growth factor (HGF), and angiogenesis-related genes, namely delta-like noncanonical Notch ligand 1 (DLK1) and platelet endothelial cell adhesion molecule-1 (PECAM1). Intraplacental tropism (adherent versus non-adherent sites in the same placenta) was driven by differences in endothelial-stromal cells with notable differences in bone morphogenic protein 5 (BMP5) and osteopontin (SPP1) in the adherent vs nonadherent site of placenta accreta spectrum. CONCLUSION: Placenta accreta spectrum disorders were characterized at single-cell resolution to gain insight into the pathophysiology of the disease. An atlas of the placenta at single cell resolution in accreta allows for understanding in the biology of the intimate maternal and fetal interaction. The contributions of stromal and endothelial cells were demonstrated through alterations in the extracellular matrix, growth factors, and angiogenesis. Transcriptional and protein changes in the stroma of placenta accreta spectrum shift the etiologic explanation away from "invasive trophoblast" to "loss of boundary limits" in the decidua. Gene targets identified in this study may be used to refine diagnostic assays in early pregnancy, track disease progression over time, and inform therapeutic discoveries.
引用
- Afshar Y, Yin O, Jeong A, et al. Placenta accreta spectrum disorder at single-cell resolution: a loss of boundary limits in the decidua and endothelium. Am J Obstet Gynecol. 2024. PMID: 38296740. doi:10.1016/j.ajog.2023.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。